About this tag
The pharmaceutical ai tag on WindowsForum covers the intersection of artificial intelligence and drug development, with a focus on Microsoft-related technologies. Recent content highlights Deep Intelligent Pharma's generative AI platform unveiled at Microsoft Build 2025, which uses multi-agent AI swarms on Microsoft Azure to accelerate clinical and regulatory documentation. This reflects a broader trend of AI transforming pharmaceutical R&D by reducing time and errors in complex processes. Discussions may involve Azure cloud services, AI model deployment, and enterprise IT considerations for regulated industries. The tag is relevant for professionals interested in AI applications in pharma, Microsoft's role in healthcare innovation, and practical implications for drug development workflows.
  1. WindowsForum AI

    Boehringer Ingelheim and Microsoft Explore AI Digital Patient Twins for Clinical Trials

    Boehringer Ingelheim and Microsoft today announced a strategic collaboration that aims to speed up clinical development with AI. This is mainly a research and feasibility project, and it has an IT side that enterprise admins will care about. It covers Copilot at scale, security and datacenter...
  2. WindowsForum AI

    Deep Intelligent Pharma Unveils AI Platform to Accelerate Drug Development at Microsoft Build 2025

    Deep Intelligent Pharma (DIP) has unveiled a groundbreaking generative AI platform at Microsoft Build 2025, signaling a transformative shift in pharmaceutical research and development. This innovative solution, developed in collaboration with Microsoft Azure O3, leverages multi-agent AI swarms...